| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |